Deliver to
United Kingdom
Order number: 35E5.1
Part number: AC100008397
Manufactured to meet research and production requirements, the HPLC column NUCLEODUR ® C 18 Gravity offers an ideal solution for reversed phase separations due to its high density C 18 phase based on high purity NUCLEODUR ® silica gel. Its endcapping feature suppresses unwanted polar interactions, making it suitable for the separation of basic and other ionizable analytes. With enhanced pH stability, LC/MS suitability, and superior base deactivation, this column is a valuable asset for RP applications, particularly for method development. It features a particle size of 5 μm, a specific surface area of 340 m²/g, and a temperature stability of up to 60°C, ensuring reliable performance under various conditions. The column's dimensions of 50 x 4 mm make it suitable for a wide range of applications, including pharm
| Name | Value | |
|---|---|---|
| Phase | : | C 18 Gravity |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | HPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L1 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-11,0 |
| Column volume | : | 0.62 ml |
| Particle size | : | 5 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | NUCLEOSIL ® C 18 HD Xterra ® RP 18 / MS C 18 Luna ® C 18 (2) Gemini ® Synergi™ Max RP Zorbax ® Extend C 18 Inertsil ® ODS III Purospher ® Star RP-18 Hypersil™ BDS |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Base deactivated (BDS), High density octadecyl (C 18 , ODS) modification |
| Pressure stability | : | 600 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 50 x 4 mm |
| Recommended application(s) | : | In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic (van der Waals) |
© 2026 Copyright. All Rights Reserved.
© 2026 Copyright. All Rights Reserved.
